[Journal logo]

Volume 64 
Part 5 
Page o881  
May 2008  

Received 4 April 2008
Accepted 17 April 2008
Online 23 April 2008

Key indicators
Single-crystal X-ray study
T = 296 K
Mean [sigma](C-C) = 0.006 Å
R = 0.071
wR = 0.170
Data-to-parameter ratio = 14.0
Details
Open access

5,6-Dichloro-2-(3-methoxyphenyl)isoindoline-1,3-dione

aDepartment of Physics, Faculty of Arts and Sciences, Ondokuz Mayis University, TR-55139 Kurupelit Samsun, Turkey, and bDepartment of Chemistry, Faculty of Arts and Sciences, Ondokuz Mayis University, TR-55139 Kurupelit Samsun, Turkey
Correspondence e-mail: orhanb@omu.edu.tr

The title compound, C15H9Cl2NO3, crystallizes as an inversion twin, the ratio of the twin components being 0.43 (13):0.57 (13). The isoindoline group is planar and inclined by 77.63 (3)° to the aromatic ring substituent. The crystal structure is stabilized by aromatic [pi]-[pi] stacking interactions involving the benzene rings of adjacent isoindoline groups, with a centroid-centroid distance of 3.664 (7) Å and an interplanar separation of 3.409 Å.

Related literature

For general background, see: Chapman et al. (1979[Chapman, J. M., Cocolas, G. H. & Hall, I. H. (1979). J. Med. Chem. 22, 1399-1402.]); Hall et al., (1983[Hall, I. H., Voorstad, P. J., Chapman, J. M. & Cocolas, G. H. (1983). J. Pharm. Sci. 72, 845-851.]; 1987[Hall, I. H., Reynolds, D. J., Wong, O. T., Oswald, C. B. & Murthy, A. R. K. (1987). Pharm. Res. 4, 472-479.]); Srivastava et al. (2001[Srivastava, R. M., Oliveira, F. J. S., da Silva, L. P., de Freitas Filho, J. R., Oliveira, S. P. & Lima, V. L. M. (2001). Carbohydr. Res. 332, 335-340.]); Abdel-Hafez (2004[Abdel-Hafez, A. A. M. (2004). Arch. Pharm. Res. 27, 495-501.]); Sena et al. (2007[Sena, V. L. M., Srivastava, M. R., de Simone, C. A., da Cruz Gonçalves, S. M., Silva, R. O. & Pereira, M. A. (2007). J. Braz. Chem. Soc. 18, 1224-1234.]).

[Scheme 1]

Experimental

Crystal data
  • C15H9Cl2NO3

  • Mr = 322.13

  • Orthorhombic, P 21 21 21

  • a = 6.8689 (5) Å

  • b = 9.7362 (10) Å

  • c = 20.4271 (14) Å

  • V = 1366.1 (2) Å3

  • Z = 4

  • Mo K[alpha] radiation

  • [mu] = 0.48 mm-1

  • T = 296 K

  • 0.65 × 0.51 × 0.23 mm

Data collection
  • Stoe IPDSII diffractometer

  • Absorption correction: integration (X-RED32; Stoe & Cie, 2002[Stoe & Cie (2002). X-AREA and X-RED32. Stoe & Cie, Darmstadt, Germany.]) Tmin = 0.685, Tmax = 0.888

  • 6123 measured reflections

  • 2687 independent reflections

  • 2076 reflections with I > 2[sigma](I)

  • Rint = 0.117

Refinement
  • R[F2 > 2[sigma](F2)] = 0.071

  • wR(F2) = 0.169

  • S = 1.00

  • 2687 reflections

  • 192 parameters

  • H-atom parameters constrained

  • [Delta][rho]max = 0.63 e Å-3

  • [Delta][rho]min = -0.57 e Å-3

  • Absolute structure: Flack (1983[Flack, H. D. (1983). Acta Cryst. A39, 876-881.]), 1114 Friedel pairs

  • Flack parameter: 0.43 (13)

Data collection: X-AREA (Stoe & Cie, 2002[Stoe & Cie (2002). X-AREA and X-RED32. Stoe & Cie, Darmstadt, Germany.]); cell refinement: X-AREA; data reduction: X-RED32 (Stoe & Cie, 2002[Stoe & Cie (2002). X-AREA and X-RED32. Stoe & Cie, Darmstadt, Germany.]); program(s) used to solve structure: SHELXS97 (Sheldrick, 2008[Sheldrick, G. M. (2008). Acta Cryst. A64, 112-122.]); program(s) used to refine structure: SHELXL97 (Sheldrick, 2008[Sheldrick, G. M. (2008). Acta Cryst. A64, 112-122.]); molecular graphics: ORTEP-3 for Windows (Farrugia, 1997[Farrugia, L. J. (1997). J. Appl. Cryst. 30, 565.]); software used to prepare material for publication: WinGX (Farrugia, 1999[Farrugia, L. J. (1999). J. Appl. Cryst. 32, 837-838.]).


Supplementary data and figures for this paper are available from the IUCr electronic archives (Reference: RZ2205 ).


Acknowledgements

The authors acknowledge the Faculty of Arts and Sciences, Ondokuz Mayis University, Turkey, for the use of the Stoe IPDSII diffractometer (purchased under grant F.279 of the University Research Fund).

References

Abdel-Hafez, A. A. M. (2004). Arch. Pharm. Res. 27, 495-501.  [PubMed] [ChemPort]
Chapman, J. M., Cocolas, G. H. & Hall, I. H. (1979). J. Med. Chem. 22, 1399-1402.  [CrossRef] [ChemPort] [PubMed]
Farrugia, L. J. (1997). J. Appl. Cryst. 30, 565.  [CrossRef] [details]
Farrugia, L. J. (1999). J. Appl. Cryst. 32, 837-838.  [CrossRef] [details]
Flack, H. D. (1983). Acta Cryst. A39, 876-881.  [CrossRef] [details]
Hall, I. H., Reynolds, D. J., Wong, O. T., Oswald, C. B. & Murthy, A. R. K. (1987). Pharm. Res. 4, 472-479.  [CrossRef] [ChemPort] [PubMed]
Hall, I. H., Voorstad, P. J., Chapman, J. M. & Cocolas, G. H. (1983). J. Pharm. Sci. 72, 845-851.  [CrossRef] [ChemPort] [PubMed]
Sena, V. L. M., Srivastava, M. R., de Simone, C. A., da Cruz Gonçalves, S. M., Silva, R. O. & Pereira, M. A. (2007). J. Braz. Chem. Soc. 18, 1224-1234.  [CrossRef] [ChemPort]
Sheldrick, G. M. (2008). Acta Cryst. A64, 112-122.  [CrossRef] [details]
Srivastava, R. M., Oliveira, F. J. S., da Silva, L. P., de Freitas Filho, J. R., Oliveira, S. P. & Lima, V. L. M. (2001). Carbohydr. Res. 332, 335-340.  [CrossRef] [PubMed] [ChemPort]
Stoe & Cie (2002). X-AREA and X-RED32. Stoe & Cie, Darmstadt, Germany.


Acta Cryst (2008). E64, o881  [ doi:10.1107/S1600536808010659 ]

This is an open-access article distributed under the terms of the Creative Commons Attribution Licence, which permits unrestricted use, distribution, and reproduction in any medium, provided the original authors and source are cited.